Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients

BACKGROUND: Sevelamer is an alternative to calcium carbonate for the treatment of hyperphosphatemia among non-dialysis dependent patients with chronic kidney disease (CKD). Although some studies show that it may reduce mortality and delay the onset of dialysis when compared to calcium carbonate, it...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Nephrol
Main Authors: Nguyen, Hai V., Bose, Saideep, Finkelstein, Eric
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2016
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848865/
https://ncbi.nlm.nih.gov/pubmed/27121505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-016-0256-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker